Cost-effectiveness of midomafetamine-assisted therapy (MDMA-AT) in chronic and treatment-resistant post-traumatic stress disorder of moderate or higher severity: A health-economic model

• Filip Stanicic ,

  Contributed equally to this work with: Filip Stanicic, Vladimir Zah, Dimitrije Grbic

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation HEOR Department, ZRx Outcomes Research Inc., Mississauga, Ontario, Canada

  ⨯
• Vladimir Zah ,

  Contributed equally to this work with: Filip Stanicic, Vladimir Zah, Dimitrije Grbic

  Roles Conceptualization, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing – review & editing

  * E-mail: vladzah@outcomesresearch.ca

  Affiliation HEOR Department, ZRx Outcomes Research Inc., Mississauga, Ontario, Canada

  https://orcid.org/0000-0003-1368-4491

  ⨯
• Dimitrije Grbic ,

  Contributed equally to this work with: Filip Stanicic, Vladimir Zah, Dimitrije Grbic

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation HEOR Department, ZRx Outcomes Research Inc., Mississauga, Ontario, Canada

  ⨯
• Debra De Angelo

  Roles Conceptualization, Data curation, Funding acquisition, Resources, Supervision, Validation, Writing – review & editing

  Affiliation Medical Affairs Department, Lykos Therapeutics, San Jose, California, United States of America

  ⨯